Anand Prakash Dubey

Dr. Anand Prakash Dubey


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
ADAnand Prakash Dubey
Anand Prakash Dubey
KRKrishnan Rajeshwari
Krishnan Rajeshwari
ACAnita Chakravarty
Anita Chakravarty
GFGiuseppe Famularo
Giuseppe Famularo
We conducted a double-blind randomized placebo-controlled study to evaluate efficacy and tolerability of VSL[sharp]3 (CD Pharma India) in the treatment of acute rotavirus diarrhea in children. The patients were randomly assigned to receive 4 days of oral treatment with VSL[sharp]3 probiotic mixture or placebo in addition to usual care for diarrhea. Out of 230 rotavirus-positive acute diarrhea children, 224 children completed the study, (113 in the drug group and 111 in the placebo group). At recruitment on Day 1, there were no significant differences between the 2 groups in terms of frequency of vomiting, mean loose stool frequency, stool consistency, and mean frequency of oral rehydration salts (ORS) and intravenous fluids administered. On Day 2, a lower mean stool frequency and improved stool consistency was noted in the drug group, which achieved statistical significance. This was also reflected in the lower volume of ORS administration in the drug group. Even on Day 3, mean loose stool frequency and frequency of ORS use and frequency of intravenous fluid use was significantly lower in the drug group. The differences in the frequency of loose stools persisted till 8 hours of Day 4. After this, as the placebo group also showed spontaneous improvement the difference between the 2 groups in terms of the overall stools frequency became comparable. However, the overall ORS requirement continued to be significantly lower in the drug group even on Day 4. The overall recovery rates were significantly better in the drug group compared with placebo. No side effects were noted with the use of the probiotic mixture. Use of probiotic mixture VSL[sharp]3 in acute rotavirus diarrhea resulted in earlier recovery and reduced frequency of ORS administration reflecting decreased stool volume losses during diarrhea.

1 July 2008 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ADAnand Prakash Dubey
Anand Prakash Dubey
APA. Parakh
A. Parakh
SDS. Dublish
S. Dublish

1 July 2003 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ADAnand Prakash Dubey
Anand Prakash Dubey
SBS. Banerjee
S. Banerjee

5 February 2014 in South African Journal of Child Health
Verified
Journal Article
Open access
PDF file
SMSumit Mehndiratta
Sumit Mehndiratta
KRKrishnan Rajeshwari
Krishnan Rajeshwari
ADAnand Prakash Dubey
Anand Prakash Dubey
RKRajesh Kumar
Rajesh Kumar

1 August 2007
Verified
Journal Article
Closed access
ADAnand Prakash Dubey
Anand Prakash Dubey
SSS Sudha
S Sudha
APAnkit Parakh
Ankit Parakh

1 March 2006
Verified
Journal Article
Closed access
ADAnand Prakash Dubey
Anand Prakash Dubey
SSS Sudha
S Sudha
APAnkit Parakh
Ankit Parakh